Gene · 3588
Papers2,588
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,588
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Analyses of plasma inflammatory proteins reveal biomarkers predictive of subsequent development of giant cell arteritis: a prospective study. | Rheumatology (Oxford) | 2023 | 36255228 | PubTator, text mining | PubMed |
| RNA-Sequencing Analysis Identifies Etiology Specific Transcriptional Signatures in Neonatal Acute Liver Failure. | J Pediatr | 2023 | 36195310 | PubTator, text mining | PubMed |
| Hyperimmunoglobulin D Syndrome Presenting with Volvulus Due to Abdominal Fibro-Inflammatory Bands. | Turk Arch Pediatr | 2023 | 36148670 | PubTator, text mining | PubMed |
| Transcriptome-wide summary data-based Mendelian randomization analysis reveals 38 novel genes associated with severe COVID-19. | J Med Virol | 2023 | 36127160 | PubTator, text mining | PubMed |
| Inflammation and retinal degenerative diseases. | Neural Regen Res | 2023 | 36018156 | PubTator, text mining | PubMed |
| Chromosomal Numerical Aberrations and Rare Copy Number Variation in Patients with Inflammatory Bowel Disease. | J Crohns Colitis | 2023 | 35907265 | PubTator, text mining | PubMed |
| Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination. | Clin Infect Dis | 2023 | 35869848 | PubTator, text mining | PubMed |
| Blockade of interleukin 10 potentiates antitumour immune function in human colorectal cancer liver metastases. | Gut | 2023 | 35705369 | PubTator, text mining | PubMed |
| Molecular and cellular factors determining the functional pleiotropy of cytokines. | FEBS J | 2023 | 35246947 | PubTator, text mining | PubMed |
| Virus interference in CoViD-19. | Bioinformation | 2022 | 37426505 | PubTator, text mining | PubMed |
| Gastrointestinal disorders and intestinal bacteria: Advances in research and applications in therapy. | Front Med (Lausanne) | 2022 | 36825261 | PubTator, text mining | PubMed |
| Immune cell-specific smoking-related expression characteristics are revealed by re-analysis of transcriptomes from the CEDAR cohort. | Cent Eur J Immunol | 2022 | 36817262 | PubTator, text mining | PubMed |
| Isolation and characterization of the mink interferon-epsilon gene and its antiviral activity. | Front Vet Sci | 2022 | 36776547 | PubTator, text mining | PubMed |
| Preclinical species gene expression database: Development and meta-analysis. | Front Genet | 2022 | 36733943 | PubTator, text mining | PubMed |
| Integrative analysis of WDR12 as a potential prognostic and immunological biomarker in multiple human tumors. | Front Genet | 2022 | 36726716 | PubTator, text mining | PubMed |
| Angiogenesis-related gene signatures reveal the prognosis of cervical cancer based on single cell sequencing and co-expression network analysis. | Front Cell Dev Biol | 2022 | 36712973 | PubTator, text mining | PubMed |
| Selection signature analysis and genome-wide divergence of South African Merino breeds from their founders. | Front Genet | 2022 | 36685923 | PubTator, text mining | PubMed |
| Discovery and Validation of a SIT1-Related Prognostic Signature Associated with Immune Infiltration in Cutaneous Melanoma. | J Pers Med | 2022 | 36675674 | PubTator, text mining | PubMed |
| Pan-cancer analysis of DEPDC1 as a candidate prognostic biomarker and associated with immune infiltration. | Ann Transl Med | 2022 | 36660720 | PubTator, text mining | PubMed |
| Integrated bioinformatics analysis of IFITM1 as a prognostic biomarker and investigation of its immunological role in prostate adenocarcinoma. | Front Oncol | 2022 | 36591519 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3588/papers?page=20